Mycenax Biotech Inc 4726 Pharmaceuticals Healthcare Deals and Alliances...
SummaryMycenax Biotech Inc Mycenax is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates...
View ArticleRP Management LLC Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryRP Management LLC RP Management is a life sciences financing company which offers biopharmaceutical products. Its products portfolio includes rituxan atripla thalomid myozyme lexiscan januvia...
View ArticleMatrix Metalloproteinase 9 Gelatinase B or 92 kDa Type IV Collagenase or 92...
Matrix Metalloproteinase 9 Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35 Pipeline Review H1 2018SummaryAccording to the recently published report 'Matrix...
View ArticleMycenax Biotech Inc 4726 Financial and Strategic SWOT Analysis Review Report...
SummaryMycenax Biotech Inc Mycenax is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates...
View ArticlePromethera Biosciences Acquires Baliopharm AG to Strengthen its Therapeutic...
Transaction Underpins Prometheras Commitment to Become the Leading Drug Developer in Severe Liver Diseases Promethera Biosciences SA a global innovator in cellbased medicines and liver diseases today...
View ArticleSigmoid Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySigmoid Pharma Ltd Sigmoid formerly known as Sigmoid Biotechnologies Ltd focuses on the development of therapeutics for unmet clinical needs in gastrointestinal and immunological diseases and...
View ArticleHMP Announces Live Presentation of the Sherman Prize for Excellence in Crohns...
Nominations are being accepted through April 25 for this annual award honoring outstanding contributions in IBD with a financial prize and national recognitionMALVERN Pa. PRWEB April 10 2018 To further...
View ArticleFujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize...
Fujifilm Kyowa Kirin Biologics Co. Ltd. today announced the company will partner with Mylan N.V. NASDAQMYL to commercialize FKB327 a biosimilar to HumiraĆ adalimumab developed by Fujifilm Kyowa Kirin...
View ArticleTiGenix reports 2017 full year results
PRESS RELEASE Regulated information inside information TiGenix reports 2017 full year results Leuven BELGIUM April 12 2018 700h CEST TiGenix NV Euronext Brussels and NASDAQ TIG an advanced...
View Article20152023 World PEGylated Proteins Market Research Report by Product Type...
SummaryxxxThis report includes market status and forecast of global and major regions with introduction of vendors regions product types and end industries; and this report counts product types and end...
View ArticleLongterm Efficacy Safety of Ustekinumab in Refractory CD
This study evaluated the longterm efficacy and safety of ustekinumab in antiTNF refractory Crohn's disease patients. Alimentary Pharmacology & Therapeutics
View ArticleQu Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryQu Biologics Inc Qu Biologics develops site specific immunomodulators SSI's that restore the body's innate immune system to treat immunerelated diseases and cancer. Its site specific...
View ArticleHelmsley Charitable Trust awards Critical Path Institute a grant to focus on...
Critical Path Institute CPath The Leona M. and Harry B. Helmsley Charitable Trust has awarded Critical Path Institute CPath a grant to support a Crohn's disease biomarker preconsortium. The...
View ArticleImmune Pharmaceuticals Inc IMNP Financial and Strategic SWOT Analysis Review...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer....
View ArticleAssociation possible between gut bacteria uveitis
A study showed a possible link between bacteria in the gut and the development of ocular manifestations particularly uveitis in patients with inflammatory bowel disease.According to study data...
View ArticleVedolizumabtreated CD Patients Undergoing Abdominal Surgery
Biologic therapies are known to increase infection risk. How does vedolizumab impact the incidence of postoperative infectious complications among Crohn's disease patients Alimentary Pharmacology &...
View ArticleGreat Minds Think Similarly The Pros and Cons of Biosimilars
Elie J. Diner April 17 2018 Ever wish you could replicate the taste of that $200 bottle of wine that has been aged to perfection over the past four decades This task is a near impossibility as it...
View ArticleQu Biologics Begins Phase 2 Clinical Trial in Crohns Disease
VANCOUVER British Columbia April 18 2018 GLOBE NEWSWIRE Qu Biologics Inc. Qu a Vancouver Canadabased biopharmaceutical company developing Site Specific Immunomodulators SSIs a unique platform of...
View ArticleDynamo develops arthritis due to Crohns disease Independent Online
Independent OnlineDynamo develops arthritis due to Crohn's diseaseIndependent OnlineDynamo's Crohn's disease has caused him to develop arthritis and he has put on two stone in recent months. The...
View Article